LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 6479

Search options

  1. Book ; Online ; E-Book: Bipolar disorder

    Young, A. H. / Juruena, Mario F.

    from neuroscience to treatment

    (Current Topics in Behavioral Neurosciences ; v.48)

    2021  

    Author's details Allan H. Young, Mario F. Juruena, editors
    Series title Current Topics in Behavioral Neurosciences ; v.48
    Keywords Bipolar disorder/Treatment ; Trastorn bipolar ; Terapèutica
    Subject code 616.89506
    Language English
    Size 1 online resource (viii, 325 pages)
    Publisher Springer
    Publishing place Cham, Switzerland
    Document type Book ; Online ; E-Book
    Remark Zugriff für angemeldete ZB MED-Nutzerinnen und -Nutzer
    ISBN 3-030-72143-4 ; 3-030-72142-6 ; 978-3-030-72143-5 ; 978-3-030-72142-8
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    Kategorien

  2. Article: Case of Addison's or Bronzed Disease.

    Young, A

    Chicago medical examiner

    2023  Volume 9, Issue 1, Page(s) 5–6

    Language English
    Publishing date 2023-07-20
    Publishing country United States
    Document type Journal Article
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Stramonium in Neuralgia.

    Young, A

    Chicago medical examiner

    2023  Volume 1, Issue 10, Page(s) 594

    Language English
    Publishing date 2023-07-20
    Publishing country United States
    Document type Journal Article
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Apadamtase Alfa: First Approval.

    Heo, Young-A

    Drugs

    2024  

    Abstract: Apadamtase alfa (ADAMTS13, recombinant-krhn; ADZYNMA), a human recombinant form of a disintegrin and metalloproteinase with thrombospondin motifs 13 (ADAMTS13), is being developed by Takeda under license from KM biologics for thrombotic thrombocytopenic ... ...

    Abstract Apadamtase alfa (ADAMTS13, recombinant-krhn; ADZYNMA), a human recombinant form of a disintegrin and metalloproteinase with thrombospondin motifs 13 (ADAMTS13), is being developed by Takeda under license from KM biologics for thrombotic thrombocytopenic purpura (TTP) and sickle cell disease. On 9 November 2023, apadamtase alfa was approved in the USA for prophylactic and on-demand enzyme replacement therapy (ERT) in paediatric and adult patients with congenital TTP. Apadamtase alfa is under regulatory review for congenital TTP in the EU and Japan, and is under clinical development for immune-mediated TTP in several countries worldwide. Clinical development of apadamtase alfa for vaso-occlusive crisis related to sickle cell anaemia is underway in the USA. This article summarizes the milestones in the development of apadamtase alfa leading to this first approval in the USA for congenital TTP.
    Language English
    Publishing date 2024-02-29
    Publishing country New Zealand
    Document type Journal Article ; Review
    ZDB-ID 120316-2
    ISSN 1179-1950 ; 0012-6667
    ISSN (online) 1179-1950
    ISSN 0012-6667
    DOI 10.1007/s40265-024-02007-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: The Treatment of Incipient Insanity.

    Young, A D

    Texas medical journal (Austin, Tex.)

    2023  Volume 21, Issue 8, Page(s) 285–286

    Language English
    Publishing date 2023-03-23
    Publishing country United States
    Document type Journal Article
    ISSN 0892-8495
    ISSN 0892-8495
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Efgartigimod Alfa in Generalised Myasthenia Gravis: A Profile of Its Use.

    Heo, Young-A

    CNS drugs

    2023  Volume 37, Issue 5, Page(s) 467–473

    Abstract: Intravenous efgartigimod alfa (also known as efgartigimod alfa-fcab in the USA; ... ...

    Abstract Intravenous efgartigimod alfa (also known as efgartigimod alfa-fcab in the USA; Vyvgart
    MeSH term(s) Adult ; Infant, Newborn ; Humans ; Quality of Life ; Myasthenia Gravis/drug therapy ; Myasthenia Gravis/chemically induced ; Antibodies, Monoclonal, Humanized ; Receptors, Cholinergic/therapeutic use ; Autoantibodies/therapeutic use
    Chemical Substances efgartigimod alfa (961YV2O515) ; Antibodies, Monoclonal, Humanized ; Receptors, Cholinergic ; Autoantibodies
    Language English
    Publishing date 2023-03-31
    Publishing country New Zealand
    Document type Randomized Controlled Trial ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1203800-3
    ISSN 1179-1934 ; 1172-7047
    ISSN (online) 1179-1934
    ISSN 1172-7047
    DOI 10.1007/s40263-023-01000-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Correction to: Efgartigimod Alfa in Generalised Myasthenia Gravis: A Profile of Its Use.

    Heo, Young-A

    CNS drugs

    2023  Volume 37, Issue 5, Page(s) 475

    Language English
    Publishing date 2023-03-03
    Publishing country New Zealand
    Document type Published Erratum
    ZDB-ID 1203800-3
    ISSN 1179-1934 ; 1172-7047
    ISSN (online) 1179-1934
    ISSN 1172-7047
    DOI 10.1007/s40263-023-01003-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Erysipelas.

    Young, A A

    Buffalo medical journal

    2023  Volume 39, Issue 11, Page(s) 821–825

    Language English
    Publishing date 2023-03-08
    Publishing country United States
    Document type Journal Article
    ZDB-ID 426473-3
    ISSN 1040-3817
    ISSN 1040-3817
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Infantile Indigestion.

    Young, A A

    Buffalo medical journal

    2023  Volume 61, Issue 8, Page(s) 471–477

    Language English
    Publishing date 2023-03-08
    Publishing country United States
    Document type Journal Article
    ZDB-ID 426473-3
    ISSN 1040-3817
    ISSN 1040-3817
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Amebic Catarrh of the Intestinal Tract.

    Young, A A

    Buffalo medical journal

    2023  Volume 35, Issue 10, Page(s) 769–773

    Language English
    Publishing date 2023-03-08
    Publishing country United States
    Document type Journal Article
    ZDB-ID 426473-3
    ISSN 1040-3817
    ISSN 1040-3817
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top